New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
08:33 EDTCBSTCubist announces availability of Sivextro in the U.S.
Cubist Pharmaceuticals announces SIVEXTRO ndicated for the treatment of adult acute bacterial skin and skin structure infections is now available in the U.S. in once-daily I.V. and oral formulations. Approved by the U.S. Food and Drug Administration on June 20, SIVEXTRO addresses ABSSSI caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus which has been categorized by the U.S. Centers for Disease Control and Prevention as a serious public health threat. Clinical studies are also ongoing for the potential use of SIVEXTRO in the treatment of hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia.
News For CBST From The Last 14 Days
Check below for free stories on CBST the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
05:33 EDTCBSTCubist opens international headquarters in Zurich, will invest $400M in R&D
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use